enGene Therapeutics ENGN
NASDAQ ENGN
$2.00 +0.05 (+2.56%)
At close: Sep 30, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Operating Expenses (2023 - 2026)

Updated

enGene Therapeutics' Operating Expenses came in at $34.01 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 13.6% from $29.95 million a year earlier and up 6.4% from the prior quarter.

Analysis

enGene Therapeutics (ENGN) Operating Expenses (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jul 31, 2026, enGene Therapeutics reported Operating Expenses of $136.65 million, up 35.1% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $123.17 million, up 97.7% from FY2024.

  • Operating Expenses has increased in each of the last three fiscal years, with a three-year compound annual growth rate of 85.1% (FY2022 to FY2025).
  • Going back by fiscal year, Operating Expenses was $62.3 million in FY2024 (+139.1%), $26.06 million in FY2023 (+34.1%) and $19.43 million in FY2022.
  • The five-year range for quarterly Operating Expenses is $4.63 million (fiscal Q1 2023) to $39.48 million (fiscal Q4 2025).
  • Year-over-year, Operating Expenses has increased for 11 consecutive quarters, with growth averaging 65.5% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Operating Expenses ranged from 13.6% (fiscal Q3 2026) to 265.4% (fiscal Q2 2024).
  • Business Quant data shows ENGN's Operating Expenses at $31.97 million (Q2 2026), $31.19 million (Q1 2026) and $39.48 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 enGene Therapeutics 130.68 Mn 130.68 Mn - 34.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 34.01 Mn
Apr 30, 2026 31.97 Mn
Jan 31, 2026 31.19 Mn
Oct 31, 2025 39.48 Mn
Jul 31, 2025 29.95 Mn
Apr 30, 2025 27.12 Mn
Jan 31, 2025 26.61 Mn
Oct 31, 2024 17.46 Mn
Jul 31, 2024 16.76 Mn
Apr 30, 2024 17.31 Mn
Jan 31, 2024 10.77 Mn
Oct 31, 2023 10.44 Mn
Jul 31, 2023 6.25 Mn
Apr 30, 2023 4.74 Mn
Jan 31, 2023 4.63 Mn
API Access

enGene Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEY